NANO Nuclear Energy Announces Second Fiscal Quarter and Recent Operational Highlights and Provides Corporate Outlook
1. NNE announces strong operational performance for Q2 2025 with key acquisitions. 2. NRC approved important milestones for KRONOS MMR, enhancing commercialization prospects. 3. NNE added $108.4 million in funding, boosting investor confidence and liquidity. 4. New demonstration facility in New York aims to advance non-nuclear component testing. 5. NNE included in the MSCI USA Index as of February 28, 2025.